Long-term gastric cancer risk in male smokers with atrophic corpus gastritis

References

• Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer [cited 2019 Jan 13]. Available from: https://gco.iarc.fr/today.
   Google Scholar
• Finnish Cancer Registry. Finnish Cancer Registry (www.cancerregistry.fi).
   Google Scholar
• Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
   PubMedGoogle Scholar
• World health organization international agency for research on cancer IARC. Monographs on the evaluation of carcinogenic risks to humans volume 61 Schistosomes, Liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
   PubMedGoogle Scholar
• Ihamaki T, Kekki M, Sipponen P, et al. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol. 1985;20:485–491.
   PubMed Web of Science ®Google Scholar
• Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–541.
   PubMed Web of Science ®Google Scholar
• Conteduca V, Sansonno D, Lauletta G, et al. H. pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013;42:5–18.
   PubMed Web of Science ®Google Scholar
• Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2–9.
   PubMed Web of Science ®Google Scholar
• Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–209.
   PubMed Web of Science ®Google Scholar
• Correa P. Serum pepsinogens in gastric cancer screening. Dig Dis Sci. 2010;55:2123–2125.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol. 2007;42:2–10.
   PubMed Web of Science ®Google Scholar
• Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008;23:351–365.
   PubMed Web of Science ®Google Scholar
• Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. Wjgo. 2010;2:342–347.
   Web of Science ®Google Scholar
• Buckland G, Travier N, Huerta JM, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137:598–606.
   PubMed Web of Science ®Google Scholar
• Gonzalez CA, Pera G, Agudo A, et al. Smoking and the risk of gastric cancer in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2003;107:629–634.
   PubMed Web of Science ®Google Scholar
• Li LF, Chan RL, Lu L, et al. Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). Int J Mol Med. 2014;34:372–380.
   PubMed Web of Science ®Google Scholar
• Telaranta-Keerie A, Kara R, Paloheimo L, et al. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol. 2010;45:1036–1041.
   PubMed Web of Science ®Google Scholar
• Kokkola A, Rautelin H, Puolakkainen P, et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol. 2000;35:138–141.
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004;57:177–182.
   PubMed Web of Science ®Google Scholar
• Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22:471–481.
   PubMed Web of Science ®Google Scholar
• Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042–1050.
   PubMed Web of Science ®Google Scholar
• de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952.
   PubMed Web of Science ®Google Scholar
• Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.
   PubMed Web of Science ®Google Scholar
• Rugge M, Meggio A, Pravadelli C, et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2018;68(1):1–7.
   Web of Science ®Google Scholar
• Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74–94.
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, OLGA Group. Staging gastritis: an international proposal. Gastroenterology. 2005;129:1807–1808.
   PubMed Web of Science ®Google Scholar
• Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150–1158.
   PubMed Web of Science ®Google Scholar
• Varis K, Taylor PR, Sipponen P, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol. 1998;33:294–300.
   PubMed Web of Science ®Google Scholar
• The ATBC Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–1035.
   PubMed Web of Science ®Google Scholar
• The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1994;4:1–10.
   PubMedGoogle Scholar
• Varis K, Sipponen P, Laxen F, et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol. 2000;35:950–956.
   PubMed Web of Science ®Google Scholar
• Price AB. The Sydney System: histological division. J Gastroenterol Hepatol. 1991;6:209–222.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014. Available from: http://www.R-project.org/.
   Google Scholar
• Malila N, Taylor PR, Virtanen MJ, et al. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control. 2002;13:617–623.
   PubMed Web of Science ®Google Scholar
• Samloff IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology. 1971;61:185–188.
   PubMed Web of Science ®Google Scholar
• Huang YK, Yu JC, Kang WM, et al. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis. PLoS One. 2015;10:e0142080.
   PubMed Web of Science ®Google Scholar
• Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138–143.
   PubMed Web of Science ®Google Scholar
• Kokkola A, Haapiainen R, Laxen F, et al. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. J Clin Pathol. 1996;49:979–984.
   PubMed Web of Science ®Google Scholar
• Steevens J, Schouten LJ, Goldbohm RA, et al. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59:39–48.
   PubMed Web of Science ®Google Scholar
• Sjodahl K, Lu Y, Nilsen TI, et al. Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer. 2007;120:128–132.
   PubMed Web of Science ®Google Scholar
• Irino T, Hiki N, Ohashi M, et al. Characteristics of gastric stump cancer: a single hospital retrospective analysis of 262 patients. Surgery. 2016;159:1539–1547.
   PubMed Web of Science ®Google Scholar
• Huang H, Wang W, Chen Z, et al. Prognostic factors and survival in patients with gastric stump cancer. World J Gastroenterol. 2015;21:1865–1871.
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Okamoto K, et al. Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy. Wjg. 2012;18:2832–2836.
   PubMed Web of Science ®Google Scholar
• Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: Pathologist's viewpoint. World J Gastroenterol. 2015;21:12179–12189.
   PubMed Web of Science ®Google Scholar